Evidence map›Paper›PMID 23553769›Full record

ArticleBlood2013

A novel syndrome of congenital sideroblastic anemia, B-cell immunodeficiency, periodic fevers, and developmental delay (SIFD).

Daniel H Wiseman, Alison May, Stephen Jolles, Philip Connor, Colin Powell, Matthew M Heeney, Patricia J Giardina, Robert J Klaassen, Pranesh Chakraborty, Michael T Geraghty and 10 more

Open access · bronzeAbstract read
In one paragraph

Article in Blood, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed, 2 pooled it
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 2 syntheses or guidelines pooled it, 113 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Kidney Involvement in Autoinflammatory Diseases.Kidney diseases (Basel, Switzerland) · 2023
    Review
  16. Review
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 13 institutions in 5 countries.

Daniel H WisemanDepartment of Haematology, Royal Manchester Children's Hospital, Manchester, United Kingdom. dwiseman@picr.man.ac.uk
Alison May
Stephen Jolles
Philip Connor
Colin Powell
Matthew M Heeney
Patricia J Giardina
Robert J Klaassen
Pranesh Chakraborty
Michael T Geraghty
Nathalie Major-Cook
Caroline Kannengiesser
Isabelle Thuret
Alexis A Thompson
Laura Marques
Stephen Hughes
Denise K Bonney
Sylvia S Bottomley
Mark D Fleming
Robert F Wynn
Royal Manchester Children's Hospital · GBUniversity of Ottawa · CABoston Children's Hospital · USCardiff University · GBCentro Hospitalar do Porto · PTChildren's Hospital of Eastern Ontario · CACornell University · USHôpital de la Timone · FRNoah's Ark Children's Hospital for Wales · GBNorthwestern University · USUniversité Paris Cité · FRUniversity Hospital of Wales · GBUniversity of Oklahoma · US

Funding

Clinical and Translational Science CenterUL1TR000457 · NCATS · WEILL MEDICAL COLL OF CORNELL UNIV · PI IMPERATO-MCGINLEY, JULIANNE L · 2012 to 2016
$46.0M
Molecular Genetics of Sideroblastic AnemiaR01DK087992 · NIDDK · BOSTON CHILDREN'S HOSPITAL · PI FLEMING, MARK D · 2011 to 2015
$2.0M
NCATS NIH HHS UL1 TR000457NIDDK NIH HHS R01 DK087892NIDDK NIH HHS R01 DK087992
6 · The paper itself

Abstract

Congenital sideroblastic anemias (CSAs) are a heterogeneous group of inherited disorders identified by pathological erythroid precursors with perinuclear mitochondrial iron deposition in bone marrow. An international collaborative group of physicians and laboratory scientists collated clinical information on cases of CSA lacking known causative mutations, identifying a clinical subgroup of CSA associated with B immunodeficiency, periodic fevers, and development delay. Twelve cases from 10 families were identified. Median age at presentation was 2 months. Anemia at diagnosis was sideroblastic, typically severe (median hemoglobin, 7.1 g/dL) and markedly microcytic (median mean corpuscular volume, 62.0 fL). Clinical course involved recurrent febrile illness and gastrointestinal disturbance, lacking an infective cause. Investigation revealed B-cell lymphopenia (CD19⁺ range, 0.016-0.22 × 10⁹/L) and panhypogammaglobulinemia in most cases. Children displayed developmental delay alongside variable neurodegeneration, seizures, cerebellar abnormalities, sensorineural deafness, and other multisystem features. Most required regular blood transfusion, iron chelation, and intravenous immunoglobulin replacement. Median survival was 48 months, with 7 deaths caused by cardiac or multiorgan failure. One child underwent bone marrow transplantation aged 9 months, with apparent cure of the hematologic and immunologic manifestations. We describe and define a novel CSA and B-cell immunodeficiency syndrome with additional features resembling a mitochondrial cytopathy. The molecular etiology is under investigation.

Indexed as

Anemia, SideroblasticB-LymphocytesDevelopmental DisabilitiesFamilial Mediterranean FeverFemaleHearing Loss, SensorineuralHumansImmunologic Deficiency SyndromesInfantInfant, NewbornMaleNervous System DiseasesPedigreePhenotypeSyndrome

Identifiers

PMID23553769
PMCPMC3761334
OpenAlexW2072324099

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.